Resources
6 Results (showing 1 - 6)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 7/7/2021 (updated 4/2/2024)
This Technical Briefing provides a description of Peer-to-Peer Distribution of Naloxone (P2PN). This is based on six case studies of pioneers of P2PN; three from the UK and three international examples that inform the guidance in this Technical Briefing. This document will inform and be extended following a pilot of P2PN in four sites in England in 2019. These will be supported by small grants from EuroNPUD. The learning from this pilot will help test the model and peer education approach promoted in this briefing.
Posted 6/16/2020 (updated 3/28/2024)
This cross-sectional study included all counties and county-equivalent divisions in the US in 2016. Data on racial/ethnic population distribution were derived from the American Community Survey, and data on locations of facilities providing methadone and buprenorphine were obtained from Substance Abuse and Mental Health Services Administration databases.
Posted 11/21/2019 (updated 3/28/2024)
Opioid overdose is reversible through the timely administration of naloxone, which has been used by emergency medical services for decades.
Posted 4/6/2020 (updated 3/28/2024)
Opioid overdose death rates were reduced in communities where overdose education and nasal naloxone distribution (OEND) was implemented. This study provides observational evidence that by training potential bystanders to prevent, recognize, and respond to opioid overdoses, OEND is an effective intervention.
Posted 6/18/2023 (updated 3/28/2024)
This report provides information on the results of the Cherokee Nation Health Services' (CNHS) hepatitis C elimination program 5 years after implementation. The report finds that the program had success with 99% of patients who completed treatment.
Posted 3/29/2023 (updated 3/27/2024)
The study has identified inherited genetic markers that are commonly inherited across addiction disorders, regardless of the substance being used. It also reinforces the role of the dopamine system within substance use disorders. This may help to further understand and implement personalized interventions for people with substance use disorders by taking into account a person's biology, environment, and lived experience.